Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call Transcript
COLL earnings call for the period ending March 31, 2019.
Collegium Pharmaceutical
COLL
COLL
$10.94
-$0.30
-2.7%
BATS BZX Real Time Price as of July 15, 2019, 4:00 p.m. EDT
View Interactive COLL Charts
COLLEGIUM PHARMACEUTICAL INC COM USD0.001
News & Analysis: Collegium Pharmaceutical
2 Big Biotech Stock Upgrades: Can They Reach These Targets?
Investment-bank analysts think these drugmakers are worth a lot more than the stock market does at the moment.
Collegium Pharmaceutical Inc (COLL) Q4 2018 Earnings Conference Call Transcript
COLL earnings call for the period ending December 31, 2018.
Here's Why Collegium Pharmaceutical Rose as Much as 23.5% Today
The company is acquiring a new drug with over $200 million in annual sales, but it won't be cheap.
Why Collegium Pharmaceutical Shares Are Tumbling 12.9% Today
The FDA is working on ways to encourage the development of abuse-deterrent opioid pain relievers, and that's potentially bad news for this tiny biotech.
Why Endo's Bad News Sent Collegium Pharmaceutical Shares Soaring 10%
Endo International has been asked by the FDA to stop selling Opana ER, clearing the way for greater use of Collegium's competing medicine.
The Best IPOs of 2015
2015 was not a particularly strong year for IPOs, but these five did quite well.
Why Collegium Pharmaceutical Is Rocketing Higher Today
The FDA is a step closer to approving Collegium Pharmaceutical's abuse-deterrent opioid pain-killer.
